Baton Rouge (Dermatology), Louisiana

Velocity Clinical Research at The Dermatology Clinic, Baton Rouge

Velocity’s Dermatology research site in Baton Rouge partners with The Dermatology Clinic & Cosmetic Center to conduct clinical trials related to skin conditions such as acne, atopic dermatitis, rosacea, and more. The Dermatology Clinic offers a wide range of treatment options to address many types of skin (dermal) issues. Offering general, surgical, pediatric, and cosmetic dermatology in-house, the clinic began conducting clinical trials with Meridian Clinical Research in 2017 before being acquired by Velocity in 2022.

Located near several other medical offices and minutes from a local hospital, the site is easily accessible to thousands of patients, including those established with the practice and diverse populations. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Baton Rouge team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Velocity Clinical Research at The Dermatology Clinic, Baton Rouge
5326 O’Donovan Dr., Baton Rouge, LA 70808

Phone: (225) 768-2850

Email: info@velocityclinical.com

Find a Clinical Trial in Baton Rouge (Dermatology)
Use the dropdown to browse current studies in Baton Rouge (Dermatology).

Follow Velocity on Facebook for company updates and more.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Baton Rouge (Dermatology)

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Baton Rouge (Dermatology) is dedicated to conducting quality research in a professional and caring environment.

  • Amie Breaux Shannon, MD

    Principal Investigator
    Amie Breaux Shannon, MD joined the Dermatology Clinic & Cosmetic Center in 2005. Board certified in Dermatology, Dr. Breaux Shannon received her medical degree from Louisiana State University School of Medicine in Shreveport, LA and completed a dermatology residency at the Medical University of South Carolina in Charleston, SC. She served as an Assistant Clinical Professor of Dermatology for three years at the Medical University of South Carolina in Charleston, SC, and is a current diplomat of the American Board of Dermatology.

  • Nicole Mathis Harrell, MD

    Principal Investigator
    Nicole Mathis Harrell, MD joined the Dermatology Clinic & Cosmetic Center in 2012. Board Certified in Dermatology, Dr. Mathis Harrell received her medical degree from Louisiana State University in New Orleans, LA and completed a dermatology internship at Earl K. Long Medical Center in Baton Rouge, LA. She also completed a dermatology residency at Louisiana State University. Dr. Mathis Harrell is a fellow of the American Academy of Dermatology.

  • Jordan Whatley, MD

    Principal Investigator
    Jordan Whatley, MD specializes in dermatology and has been in private practice since 2011. Board certified in Dermatology, Dr. Whatley received his medical degree from Louisiana State University and achieved Junior AOA and pharmacology honors. He also completed an internal medicine internship at Earl K. Long Medical Center in Baton Rouge, LA and a dermatology residency at Louisiana State University, where he served as Chief Resident his final year. Dr. Whately currently serves as an Assistant Clinical Professor for the Louisiana State University Department of Dermatology, a Diplomat of the American Board of Dermatology, and a fellow of the American Academy of Dermatology.

  • Mary Dobson, MD

    Principal Investigator
    Mary Dobson, MD joined the Dermatology Clinic & Cosmetic Center in 2008. She has been practicing medicine in Baton Rouge and Hammond, LA since 2000. Board certified in Dermatology, Dr. Dobson received her medical degree from Louisiana State University Medical School in Shreveport, LA and completed a dermatology residency at Louisiana State University Medical School in Shreveport, LA. She also completed a dermatology residency at Charity Hospital in New Orleans, LA. Dr. Dobson currently serves as an Assistant Clinical Professor of Dermatology at Earl K. Long Hospital in Baton Rouge, LA.

  • Kristen LeBleu Losavio, MD

    Sub Investigator
    Kristen LeBleu Losavio, MD joined the Dermatology Clinic & Cosmetic Center in 2016. Board certified in Dermatology, Dr. LeBleu Losavio received her medical degree from Louisiana State University in New Orleans, LA and completed an internal medicine internship at Carolinas Medical Center in Charlotte, NC. She also completed a dermatology residency at Emory University in Atlanta, GA where she served as chief resident. Dr. LeBleu Losavio is a member of American Academy of Dermatology, American Society for Dermatological Surgery, Society for Pediatric Dermatology, and Alpha Omega Alpha Honor Medical Society.

Learn More About Participating in a Clinical Trial

Liver Illustration with blog title, All About Liver Disease - Terminology, Early Detection, Symptoms and and Long Term Risk

All About Liver Disease

Liver disease is a growing concern across the globe, especially in the United States, where the prevalence of conditions like Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis … Read more

What is Informed Consent

What is Informed Consent?

Joining a clinical trial is an important decision. Most participants come to the clinic with questions about clinical trials and what joining one could mean. This is why every study … Read more

Clinical Trial Phases What Happens in Phase 1, 2, 3 and 4

Clinical Trial Phases: What Happens in Phase 1, 2, 3 and 4?

Clinical trials are research studies of medications, vaccines, medical devices, procedures, diagnostics (tests), and other health-related products. These studies involve participants (also known as patients, volunteers, or subjects) to determine … Read more

Maryann - research study participant testimonial

Participant Story: Maryann, a Research Study Participant at Velocity

What led you to participate in a research study? I saw a roadside poster near the university in my neighborhood [for a vaccine study] and called Velocity. My first experience … Read more

Complete the form to start your clinical trial journey in Baton Rouge (Dermatology)

Why join a clinical trial?

  • Help advance medicine
  • Learn about potential new medicines in development
  • Get study-related medical exams at no cost
  • Receive compensation for participating (available amounts may differ for each study)

After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.

Health insurance is generally not needed to join a clinical trial.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.